Approximately 96% of FRDA is due to homozygosity for a GAA expansion in intron 1 of FXN, with the other 4% being compound heterozygous for a GAA expansion and a different FXN pathogenic variant. This evidence concerns the gene FXN and Friedreich ataxia.